Crossmark

Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies)

Crossref DOI link: https://doi.org/10.1007/s00228-018-2603-5

Published Online: 2019-01-04

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Fialová, Daniela https://orcid.org/0000-0001-5638-9690
Laffon, Blanca

Marinković, Valentina

Tasić, Ljiljana

Doro, Peter

Sόos, Gyӧngyver

Mota, Jorge

Dogan, Soner

Brkić, Jovana

Teixeira, João Paulo

Valdiglesias, Vanessa

Costa, Solange
Funding

Funding for this research was provided by:

European Cooperation in Science and Technology (EU COST Action IS1402 “Ageism - a multi-national, interdisciplinary perspective” (2015–2018))

H2020 Marie Skłodowska-Curie Actions (EUROAGEISM Horizon 2020 project EC no. 764632 MSCA-ITN (2017–2021))
License Information

Text and Data Mining valid from 2019-01-04
More Information

Article History

Received: 20 September 2018

Accepted: 22 November 2018

First Online: 4 January 2019

Compliance with ethical standards

:

: All authors have been supported in participation at meetings of the EU COST Action IS1402 initiative “Ageism - interprofessional, multidisciplinary perspectives” (April 2015–October 2018). Dr. Fialová has been supported as Chair of the FIP7 program of the EUROAGEISM H2020 project, no. 764632, Horizon 2020-MSCA-ITN (2017–2021), and by the scientific program PROGRESS Q42 at the Faculty of Pharmacy in Hradec Králové, Charles University, Czech Republic.

Document is current

Any future updates will be listed below